Black Diamond Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BDTX and other ETFs, options, and stocks.About BDTX
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases.
CEOMark A. Velleca
CEOMark A. Velleca
Employees24
Employees24
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2014
Founded2014
Employees24
Employees24
BDTX Key Statistics
Market cap142.73M
Market cap142.73M
Price-Earnings ratio40.52
Price-Earnings ratio40.52
Dividend yield—
Dividend yield—
Average volume1.56M
Average volume1.56M
High today$2.56
High today$2.56
Low today$2.45
Low today$2.45
Open price$2.50
Open price$2.50
Volume592.10K
Volume592.10K
52 Week high$6.75
52 Week high$6.75
52 Week low$1.20
52 Week low$1.20
People also own
Based on the portfolios of people who own BDTX. This list is generated using Robinhood data, and it’s not a recommendation.